Emerald Finance Limited Delivers Strong Consolidated FY26 Results; Total Income Reaches Rs 31.20 Cr with Net Profit Surging 70%

Mumbai (Maharashtra) [India], May 29: Emerald Finance Limited (BSE: EMERALD), one of the dynamic company offering a spectrum of financial products and services including its flagship Earned Wage Access (EWA) in India, has announced its Audited Financial Results for Q4 FY26 & FY26.

Key Financial Highlights 

Standalone Key Financial Highlights – Q4 FY26:
 • Total Income of ₹5.85 Cr, YoY growth of 27%
 • EBITDA of ₹4.39 Cr, YoY growth of 27%
 • Net Profit of ₹2.78 Cr, YoY growth of 29%
 • EPS of ₹0.81, YoY growth of 29%

Consolidated Key Financial Highlights – Q4 FY26:
 • Total Income of ₹9.76 Cr, YoY growth of 50%
 • EBITDA of ₹6.83 Cr, YoY growth of 55%
 • Net Profit of ₹4.36 Cr, YoY growth of 64%
 • EPS of ₹1.27, YoY growth of 67%

Standalone Key Financial Highlights – FY26:
 • Total Income of ₹20.78 Cr, YoY growth of 54%
 • EBITDA of ₹17.41 Cr, YoY growth of 63%
 • Net Profit of ₹11.55 Cr, YoY growth of 79%
 • EPS of ₹3.33, YoY growth of 80%

Consolidated Key Financial Highlights – FY26:
 • Total Income of ₹31.20 Cr, YoY growth of 44%
 • EBITDA of ₹23.23 Cr, YoY growth of 56%
 • Net Profit of ₹15.15 Cr, YoY growth of 70%
 • EPS of ₹4.36, YoY growth of 70%

Comment on Financial Performance Mr. Sanjay Aggarwal, Managing Director of Emerald Finance Limited said, “Q4 FY26 has been a strong quarter for Emerald Finance, with meaningful progress across both our core businesses. We successfully onboarded 34 additional corporates onto our EWA platform, reinforcing its growing adoption among employers and expanding our reach within India’s formal workforce.

Our gold loan syndication business, operated through our subsidiary Eclat Net Advisors Private Limited, delivered disbursements exceeding ₹375 Cr during the quarter, in partnership with leading institutions including ICICI Bank, HDFC Bank, RBL Bank, and Muthoot Finance.

These results reflect the continued scalability of our asset-light, technology-led model and strengthen our confidence in delivering sustainable growth. With India’s financial ecosystem offering significant tailwinds, Emerald Finance remains well positioned to capitalize on emerging opportunities and create long-term value for our stakeholders.”

Q4 FY26 Key Business Highlights 

Corporate Partnerships for EWA Established partnerships with 34 leading corporatesExpanded presence in the Earned Wage Access (EWA) ecosystem
Gold Loan Disbursement Disbursed over ₹375 Cr under Gold Loan segmentStrategic partnerships with ICICI Bank, HDFC Bank, RBL Bank, and Muthoot Finance through Eclat Net Advisors Private Limited

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More